Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Shelton · SciRah

Researcher profile · Semantic Scholar

G. Shelton

Share profile

G. Shelton — researcher profile on SciRah

h-index: 9
Works: 21
Citations: 617

Most-cited papers

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer.
D. Petrylak, R. MacArthur, John O'Connor, G. Shelton +10 more
1999Journal of Clinical Oncology314 citations
Semantic Scholar
Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer.
D. Petrylak, R. MacArthur, John O'Connor, G. Shelton +11 more
1999Seminars in Oncology94 citations
Semantic Scholar
Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.
A. Weitzman, G. Shelton, N. Zuech, C. Owen +9 more
2000Journal of Urology61 citations
Semantic Scholar
Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma
S. Boorjian, M. Milowsky, J. Kaplan, M. Albert +7 more
200744 citations
Semantic Scholar
Phase I trial of interferon α2b and liposome‐encapsulated all‐trans retinoic acid in the treatment of patients with advanced renal cell carcinoma
Jonathan S. Goldberg, M. Vargas, Alyssa S. Rosmarin, M. Milowsky +6 more
2002Cancer24 citations Open access
Semantic Scholar
ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity.
L. Williams, P. Ginex, George L Ebanks, Karren Ganstwig +10 more
2020Oncology Nursing Forum22 citations
Semantic Scholar
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
S. Boorjian, M. Milowsky, J. Kaplan, M. Albert +7 more
2007Journal of immunotherapy16 citations
Semantic Scholar
Early Palliative Care for Patients With Brain Metastases Decreases Inpatient Admissions and Need for Imaging Studies
Akram A. Habibi, S. Wu, D. Gorovets, A. Sansosti +7 more
2018The American journal of hospice & palliative care14 citations
Semantic Scholar
Skin Toxicity: Clinical Summary of the ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity.
K. Wiley, George L Ebanks, G. Shelton, Jenna Strelo +1 more
2020Clinical Journal of Oncology Nursing11 citations
Semantic Scholar
Phase I/II study of docetaxel (D), gemcitabine (G), Carboplatin (C) in poor prognosis and previously treated patients (pts) with urothelial carcinoma (UTC)
A.-C. Chen, E. Hovey, G. Shelton, J. Fitzsimmons +3 more
20045 citations
Semantic Scholar
Phase I/II study of docetaxel (D), gemcitabine (G), Carboplatin (C) in poor prognosis and previously treated patients (pts) with urothelial carcinoma (UTC).
A.-C. Chen, E. Hovey, G. Shelton, J. Fitzsimmons +3 more
2004Journal of Clinical Oncology5 citations
Semantic Scholar
A phase I open-label, dose escalation study to determine the maximum tolerated dose and to evaluate the safety profile of lenalidomide with every three week docetaxel in subjects with androgen independent prostate cancer.
R. Moss, G. Shelton, J. Melia, S. Mohile +1 more
2006Journal of Clinical Oncology4 citations
Semantic Scholar
Sequential and intermittent docetaxel (D) and imatinib (Im) in hormone-refractory prostate cancer patients (NYU 04-47).
Alejandro Gomez-Pinillos, H. Ballard, G. Shelton, Mary M. Reilly +3 more
2009Journal of Clinical Oncology2 citations
Semantic Scholar
Pharmacokinetics (PK), safety and tolerability of atrasentan (ABT-627, ATN) in combination with docetaxel (DOC) in men with hormone refractory prostate cancer (HRPC).
D. Petrylak, S. Mohile, G. Shelton, R. Carr +6 more
2006Journal of Clinical Oncology2 citations
Semantic Scholar
Pursuing Nursing’s Terminal Clinical Degree, the DNP: The Practical Benefits
G. Shelton, Dnp, Anp-Bc, Aocnp
20161 citations
Semantic Scholar
Financial toxicity in patients with advanced solid malignancies participating in early-phase clinical trials.
J. Blanter, Michael Werner, Melanie W Kier, O. Hapanowicz +16 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Breathing New Life Into Lung Cancer Screening Programs
G. Shelton, Kerrin Sorrie
20170 citations
Semantic Scholar
Enzalutamide Improves Survival in Castration-Resistant Prostate Cancer
G. Shelton, Dnp, Anp-Bc, Aocnp
20130 citations
Semantic Scholar
Case Studies in the Treatment of Bladder Cancer
G. Shelton
20070 citations
Semantic Scholar
Phase I/II trial of interferon {alpha}2b and ATRA-IV in the treatment of patients with advanced renal cancer
D. Nanus, S. Boorjian, M. Milowsky, D. Coll +6 more
20050 citations
Semantic Scholar
Phase I T rial o f D ocetaxel W ith E stramustine in A ndrogen-Indepen dent P rostate C ancer
D. Petrylak, R. MacArthur, G. Shelton, Timothy W. Judge +9 more
19990 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Petrylak×12
Invite
D. Petrylak — researcher profile on SciRah
M. Milowsky×5
Invite
M. Milowsky — researcher profile on SciRah
D. Nanus×5
Invite
D. Nanus — researcher profile on SciRah
Timothy W. Judge×4
Invite
Timothy W. Judge — researcher profile on SciRah

×4

Invite

Charles Pfaff — researcher profile on SciRah

Invite

N. Zuech — researcher profile on SciRah

Invite

I. Sawczuk — researcher profile on SciRah

Invite

C. Olsson — researcher profile on SciRah

Invite

L. Gudas — researcher profile on SciRah

Invite

E. Bagiella — researcher profile on SciRah

Invite

M. Benson — researcher profile on SciRah

Invite

S. Boorjian — researcher profile on SciRah